SCHEMBL22192813

SCHEMBL22192813

CC1=C(C)N(C)C(=O)N(C)C(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL905130 0.87 — —
SCHEMBL145601 0.79 KMT2A (0.35) —
SCHEMBL31439229 0.76 KMT2A (0.33) —
SCHEMBL27915149 0.76 KMT2A (0.33) —
SCHEMBL27897658 0.76 KMT2A (0.33) —
SCHEMBL31439235 0.70 GSK3A (0.30) —
SCHEMBL17789577 0.68 — —
SCHEMBL3296583 0.68 — —
SCHEMBL23894741 0.67 GSK3A (0.38) —
SCHEMBL7945735 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10703754-B2 Compounds and compositions for treating chemical warfare agent-induced injuries ELI LILLY AND COMPANY (US) 2020-07-07 — — US disclosed
Send feedback